ORBIMED ADVISORS LLC 13D and 13G filings for MBX Biosciences, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-11 6:42 pm Sale | 2026-02-05 | 13D | MBX BIOSCIENCES INC MBX | ORBIMED ADVISORS LLC | 3,637,887 7.700% | -365,000 (-9.12%) | Filing |
| 2025-09-30 7:06 pm Purchase | 2025-09-26 | 13D | MBX BIOSCIENCES INC MBX | ORBIMED ADVISORS LLC | 4,002,887 9.000% | 190,672 (+5.00%) | Filing |
| 2024-09-23 4:34 pm Purchase | 2024-09-16 | 13D | MBX BIOSCIENCES INC MBX | ORBIMED ADVISORS LLC | 3,812,215 12.000% | 3,812,215 (New Position) | Filing |